Alcon announced that over 175 million of its intraocular lenses (IOLs) have been implanted worldwide.

The company boasts more than three decades of IOL experience with its portfolio covering the Clareon and AcrySof IQ families of IOLs, including Monofocal, Vivity, PanOptix, and PanOptix Pro. These all have Toric options and ultraviolet and blue light filtering technologies.

The milestone includes over six million of Alcon’s latest generation of presbyopia-correcting IOLs (PCIOLs) to help patients gain greater visual freedom after cataract surgery. PanOptix, introduced in 2015, represented a shift for surgeons and patients—the possibility of spectacle independence and clear vision at near, intermediate, and distance.

With over four million implants globally, it touts exceptional visual outcomes and patient satisfaction. 99% of PanOptix patients said they would have the lens implanted again. Last year, the company advanced the tech with Clareon PanOptix Pro, which is now available in the U.S., Canada, Japan, Australia, and New Zealand.

The company also developed Vivity, the first non-diffractive extended depth of focus (EDOF) IOL, which has passed two million implants. It provides a PCIOL option for patient with demanding visual needs like frequent nighttime driving, or those not a candidate for a diffractive IOL. It provides glasses-free distance and intermediate vision, along with functional near vision. The Clareon Vivity IOL earned EU clearance last year.

“Our leadership in IOLs is built on a foundation of continuous innovation—from PanOptix, the first trifocal IOL, to Vivity’s breakthrough non-diffractive wavefront design, and now PanOptix Pro with advanced light utilization and reduced scatter,” said Sean Clark, VP and GM, Global Surgical Franchise at Alcon. “These advancements empower surgeons to deliver exceptional outcomes and will help patients see brilliantly for years to come.”

Last month, the company launched its TOTAL30 multifocal for astigmatism in the U.S. According to the company, it’s the only multifocal toric lens with Water Gradient Technology, helping patients stay in lenses comfortably as their vision changes from standard correction to age-related presbyopia.